Neurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
Authors:
- Biancamaria LongoniBLBiancamaria Longoni
- Irene FascianiIFIrene Fasciani
- Ilaria PietrantoniIPIlaria Pietrantoni
- Francesco MaramponFrancesco Marampon
- Francesco PetragnanoFPFrancesco Petragnano
- Gabriella AloisiGAGabriella Aloisi
- Maria F. CoppolinoMCMaria F. Coppolino
- Marco ScarselliMarco Scarselli
- Roberto MaggioRMRoberto Maggio
- 7 January 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 25 (42) , 4510-4522
Abstract
: Exosomes are extracellular vesicles produced by eukaryotic cells that are also found in most biological fluids and tissues. While they were initially thought to act as compartments for removal of cellular debris, they are now recognized as important tools for cell-to-cell communication and for the transfer of pathogens between the cells. They have attracted particular interest in neurodegenerative diseases for their potential role in transferring prion-like proteins between neurons, and in Parkinson’s disease (PD), they have been shown to spread oligomers of α-synuclein in the brain accelerating the progression of this pathology. A potential neuroprotective role of exosomes has also been equally proposed in PD as they could limit the toxicity of α-synuclein by clearing them out of the cells. Exosomes have also attracted considerable attention for use as drug vehicles. Being nonimmunogenic in nature, they provide an unprecedented opportunity to enhance the delivery of incorporated drugs to target cells. In this review, we discuss current knowledge about the potential neurotoxic and neuroprotective role of exosomes and their potential application as drug delivery systems in PD.Keywords
This publication has 134 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology and Medicine, 2013
- PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrityHuman Molecular Genetics, 2011
- Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmissionNeurobiology of Disease, 2011
- Multivesicular bodies in neurons: Distribution, protein content, and trafficking functionsProgress in Neurobiology, 2011
- Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) SecretionJournal of Biological Chemistry, 2010
- Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synucleinProceedings of the National Academy of Sciences, 2009
- α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityNature Genetics, 2009
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- Insect sodium channels and insecticide resistanceInvertebrate Neuroscience, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006